Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Loquat Qingfei decoction granule (also known as Pipa Qingfei granules) is a traditional Chinese medicine (TCM) compound preparation derived from the ancient classic formula 'Pipa Qingfei Decoction' (枇杷清肺饮) from the Qing Dynasty's *Golden Mirror of Medicine* (*Yi Zong Jin Jian*). It is composed of six main herbal ingredients: loquat leaf (Folium Eriobotryae), mulberry bark (Cortex Mori), coptis rhizome (Rhizoma Coptidis), amur cork tree bark (Cortex Phellodendri), ginseng (Radix Ginseng), and licorice (Radix Glycyrrhizae). The formulation is primarily developed for clearing lung heat and is indicated for the treatment of acne vulgaris (specifically the lung-heat/wind-heat pattern) and seborrheic dermatitis. It has been approved for marketing in China as a Category 3.1 innovative TCM.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on loquat Qingfei decoction granule.